Dulfikar Ali, Koh Eng-Siew, Lwin Zarnie, Hovey Elizabeth, Dhillon Haryana, Arundell Jesica, Pinkham Elizabeth, Pinkham Mark B, Holland Justin, Trajano Gabriel, Naumann Fiona
School of Exercise and Nutrition Sciences, Queensland University of Technology, Kelvin Grove, Australia.
Radiation oncology, Liverpool Hospital, Liverpool, Australia.
Neurooncol Pract. 2021 Feb 22;8(3):290-298. doi: 10.1093/nop/npab015. eCollection 2021 Jun.
Few studies have assessed physical functioning in glioma patients with grade II, III, and IV glioma prior to undergoing adjuvant radiation with or without chemotherapy. The aim of this study was to describe the baseline physical functioning capacity of patients with glioma prior to adjuvant therapy compared to validated cutoffs required to maintain independence.
This study is a cross-sectional study that recruited patients with grade II, III, and IV glioma (n = 33) undergoing adjuvant radiation with or without chemotherapy. The six-minute walk, thirty-second sit-to-stand, and timed "Up & Go" assessments were used to describe baseline physical functioning. Perceived quality of life from the European Organisation for Research and Treatment of Cancer (EORTC) quality of life questionnaire (QLQ-C30) version 3.0 was used to quantify the quality of life.
Mean distance walked in the six-minute walk test was 416.2 m (SD 137.6 m) with a mean of 12.2 stands (SD 3.4 stands) achieved during the thirty-second sit-to-stand. Median time to complete the timed "Up & Go" assessment was 7 s (interquartile range: 3 s). One-sample tests suggest walking distance and chair stands were significantly lower than cutoff criterions to maintain independent living, (32) = -5.96, < .001, bias-corrected accelerated 95% CI [370.7-460.4], and (32) = -4.60, < .01, bias-corrected accelerated 95% CI [11.0-13.4], respectively. Wilcoxon signed-rank test identified significantly shorter median time taken to complete the timed "Up & Go" test compared to the cutoff criterion ( = -4.43, n = 33, < .01).
This study suggests glioma patient's aerobic endurance and lower limb strength are below criterion cutoffs recommended to maintain independent living. Timed "Up & Go" scores did not exceed the criterion cutoff, indicating respectable levels of mobility.
很少有研究评估过二级、三级和四级神经胶质瘤患者在接受辅助放疗(无论是否联合化疗)之前的身体功能状况。本研究的目的是描述神经胶质瘤患者在辅助治疗前的基线身体功能能力,并与维持独立生活所需的经过验证的临界值进行比较。
本研究为横断面研究,招募了正在接受辅助放疗(无论是否联合化疗)的二级、三级和四级神经胶质瘤患者(n = 33)。采用六分钟步行、三十秒坐立和定时“起身走”评估来描述基线身体功能。使用欧洲癌症研究与治疗组织(EORTC)生活质量问卷(QLQ-C30)3.0版来量化生活质量。
六分钟步行测试中的平均步行距离为416.2米(标准差137.6米),三十秒坐立测试中的平均坐立次数为12.2次(标准差3.4次)。完成定时“起身走”评估的中位时间为7秒(四分位间距:3秒)。单样本检验表明,步行距离和坐立次数显著低于维持独立生活的临界标准,(32)=-5.96,P <.001,偏差校正加速95%置信区间[370.7 - 460.4],以及(32)=-4.60,P <.01,偏差校正加速95%置信区间[11.0 - 13.4],。Wilcoxon符号秩检验确定,与临界标准相比,完成定时“起身走”测试所需的中位时间显著更短(Z = -4.43,n = 33,P <.01)。
本研究表明,神经胶质瘤患者的有氧耐力和下肢力量低于维持独立生活建议的临界值。定时“起身走”得分未超过临界标准,表明其活动能力处于可接受水平。